Causes of death among COVID-19 patients in Mexico City
DOI:
https://doi.org/10.21640/ns.v13ie.2850Keywords:
death, Public Health, comorbidities, COVID-19, SARS-CoV-2, coronavirus, pandemic, age, gender, arterial hypertension, diabetes, obesityAbstract
COVID-19 has caused millions of deaths around the world since its appearance in Wuhan, China in late 2019. It reached Mexico in early 2020 after it caused many casualties in western Europe. Mexico is now one of the countries with the largest death rate due to COVID-19. Mexico City is not only the largest city in Mexico, but one of the largest in the world. Fortunately, its data regarding COVID-19 patients is publicly available and can be analyzed to obtain information that may guide public policy and personal decisions.
Method: This work reports the findings of a descriptive study based on data retrieved July 28th, 2020 from the Mexico City government web page that reports suspected COVID-19 patients. Only confirmed cases were analyzed. To calculate the proportion of cases and deaths by age range in Mexico City, the population pyramid of Mexico City was used. To obtain the proportion of cases and deaths relative to population by age range, cases and deaths were adjusted to match those reported by CONACYT. Case and death frequency by gender, age range and previous health condition were calculated using a spreadsheet program. Tables and graphs were obtained using the same program.
Results and discussion: Age, gender and previous health conditions have an effect in death increase among confirmed COVID-19 patients, so that: older people have a higher mortality rate than younger people, males have a higher mortality rate than females and people with certain previous health conditions such as hypertension and diabetes have a higher mortality rate than people with no previous health conditions. Some examples are regarding the effect of age, COVID-19 patients 61 to 70 years old are twice as likely to die than those 51 to 60 years old; regarding the effect of gender, male patients 51 to 60 years old are more than twice as likely to die than female patients their same age and, regarding the effect of previous health conditions, female patients with hypertension are six times as likely to die than female patients with no previous health condition.
Conclusion: According to the information available and analyzed in this work, age, gender, and previous health condition are important causes for death rate among COVID-19 patients in Mexico City.
Downloads
References
Ahrenfeldt, L.J., Otavova, M., Christensen, K. et al. . (2020). Sex and age differences in COVID-19 mortality in Europe. Wien Klin Wochenschr. doi: https://doi.org/10.1007/s00508-020-01793-9
Angel, A. (2021). Cifra real de muertos por COVID es casi 45% más de lo reportado por Salud: Inegi. Animal Político, January 27th, 2021. Retrieved from https://www.animalpolitico.com/2021/01/cifra-real-muertos-por-covid-mas-de-lo-reportado-por-salud-inegi/
Cai R., Zhang J., Zhu Y., Liu L., Liu Y., He Q. (2021). Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. 2021 Jan 3 : 1–7. doi: https://doi.org/10.1007/s11255-020-02740-3
Capuano A, Rossi F and Paolisso G (2020) Covid-19 Kills More Men Than Women: An Overview of Possible Reasons. Frontiers in Cardiovascular Medicine 7:131. doi: https://doi.org/10.3389/fcvm.2020.00131
CONACYT (2020). covid-19 México, Datos generales. Retrieved July 30th, 2020 from https://coronavirus.gob.mx/datos/
Dehingia N. y Raj A. (2020). Sex differences in COVID-19 case fatality: do we know enough? The Lancet Global Health. doi: https://doi.org/10.1016/S2214-109X(20)30464-2
Du Y., Zhou N., Zha W., Lv Y. (2021). Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, Volume 31, Issue 3, 2021, Pages 745-755, ISSN 0939-4753. doi: https://doi.org/10.1016/j.numecd.2020.12.009
Escobedo-de la Peña J., Rascón-Pacheco R. A., Ascencio-Montiel I. J., González-Figueroa E., Fernández-Gárate J. E., Medina-Gómez O. S., Borja-Bustamante P., Santillán-Oropeza J. A., Borja-Aburto V. H. (2020). Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients With COVID-19 in Mexico, Archives of Medical Research, 2020, ISSN 0188-4409. doi: https://doi.org/10.1016/j.arcmed.2020.12.002
Flannery N. (2020). Why are so many young people dying of covid-19 in Mexico City? Forbes, July 24th, 2020. Retrieved from https://www.forbes.com/sites/nathanielparishflannery/2020/07/24/why-are-so-many-young-people-dying-of-covid-19-in-mexico-city/#6000c5202792
Global Health 50/50 (2021). Cases and death by sex and age. Retrieved April 4th, 2021 from https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker
Gobierno de la CDMX (2017). Población. Retrieved from http://data.salud.cdmx.gob.mx/portal/media/agenda_2017/pdfs/1SN/poblacion.pdf
Gobierno de la CDMX (2020). COVID SINAVE CDMX. Retrieved July 28th, 2020 from https://datos.cdmx.gob.mx/explore/dataset/base-covid-sinave/table/
Harvard GenderSci Lab (2021). US Gender/Sex COVID-19 Data Tracker. Retrieved March 19th, 2021 from https://www.genderscilab.org/gender-and-sex-in-covid19/#AgeAdjustedRates
INEGI (2021). Características de las defunciones registradas en México durante enero a agosto de 2020. Retrieved from https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/DefuncionesRegistradas2020_Pnles.pdf
Johns Hopkins Coronavirus Resource Center (2021). Mortality Analyses. Retrieved March 7th, 2021 from https://coronavirus.jhu.edu/data/mortality
Johns Hopkins Bloomberg School of Public Health, News Release (2021). COVID-19 Outcomes for Patients on Immunosuppressive Drugs on Par with Non-Immunosuppressed Patients. January 7th, 2021. Retrieved from https://www.jhsph.edu/news/news-releases/2021/covid-19-outcomes-for-patients-on-immunosuppressive-drugs-on-par-with-non-immunosuppressed-patients.html
Lee, S.C., Son, K.J., Han, C.H. et al. (2021). Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea. Sci Rep 11, 3735 (2021). doi: https://doi.org/10.1038/s41598-021-83226-9
Mallapaty S. (2020). The coronavirus is most deadly if you are older and male — new data reveal the risks. Nature 585, 16-17 (2020). doi: https://doi.org/10.1038/d41586-020-02483-2
Novosad P., Jain R., Campion A., Asher S. (2020). COVID-19 mortality effects of underlying health conditions in India: a modelling study. BMJ Open 2020;10:e043165. Retrieved from https://bmjopen.bmj.com/content/10/12/e043165
Onorato D., Carpenè G., Lippi G., and Pucci M. (2020). Updated overview on the interplay between obesity and COVID-19. doi: https://doi.org/10.1515/dx-2020-0111
Peckham, H., de Gruijter, N.M., Raine, C. et al. . (2020). Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communication 11, 6317. doi: https://doi.org/10.1038/s41467-020-19741-6
Populationpyramid.net (2020). Population Pyramids of the World from 1950 to 2100. Retrieved from https://www.populationpyramid.net/
Romero-Zavala M. and Despeguel L. (2020). ¿Qué nos dicen las actas de defunción de la CDMX?. Nexos, September 3rd, 2020
Roser M., Ritchie H., Ortiz-Ospina E., and Hasell J. (2021). Cumulative COVID-19 test per 1,000 people. Retrieved April 7th, 2021 from https://ourworldindata.org/covid-cases
The Economist (2020). When covid-19 deaths are analyzed by age, America is an outlier. The Economist, June 24th, 2020. Retrieved from https://www.economist.com/graphic-detail/2020/06/24/when-covid-19-deaths-are-analysed-by-age-america-is-an-outlier
World Health Organization (2021). WHO Coronavirus (COVID-19) Dashboard. Retrieved March 7th, 2021 from https://covid19.who.int/
Wu, Zh., Tang, Y. & Cheng, Q. Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol 58, 139–144 (2021). doi: http://doi.org/10.1007/s00592-020-01546-0
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nova Scientia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Conditions for the freedom of publication: the journal, due to its scientific nature, must not have political or institutional undertones to groups that are foreign to the original objective of the same, or its mission, so that there is no censorship derived from the rigorous ruling process.
Due to this, the contents of the articles will be the responsibility of the authors, and once published, the considerations made to the same will be sent to the authors so that they resolve any possible controversies regarding their work.
The complete or partial reproduction of the work is authorized as long as the source is cited.
